Telma D tablet belongs to the group of medications called antihypertensives. It contains a combination of two medications, Telmisartan and Indapamide, which control blood pressure when a single medication is ineffective. It is primarily used for the treatment of hypertension. Hypertension (high blood pressure) is a medical condition in which blood exerts a force on the artery walls (blood vessels), resulting in heart disease, irregular heartbeat, and other problems.

Nausea, diarrhea, headache, dizziness, weakness, stomach pain, constipation, infection, nose inflammation, chest pain, back pain, indigestion, nervousness, peripheral edema, sore throat, and cough are the common side effects of Telma D tablet. Inform your healthcare provider if these side effects disturb or persist in you. Before treatment with Telma D tablet, let your physician know if you are experiencing any allergic reaction to Telmisartan or Indapamide and its ingredients. Report to your physician if you have kidney or severe liver diseases, heart rhythm problems, vision problems or eye pain, muscle disorders, a low potassium level (hypokalemia), blood pressure, and the number of electrolytes (potassium) in your blood at regular intervals. It is not recommended for pregnant and breastfeeding women.

• Treats hypertension (high blood pressure). 

Telmisartan works by preventing the action of certain substances that tighten blood vessels (arteries). It improves blood flow and increases the heart's ability to pump blood effectively throughout the body. Indapamide eliminates excess water and electrolytes from the body. Furthermore, it relaxes blood vessels and improves blood flow. They reduce blood pressure and minimize the risk of heart attack, stroke, and edema (fluid retention).

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Telmisartan + Indapamide and cause undesirable side effects.

• Store below 30°C in a dry place.
• Protect from light and moisture.
• Keep Telma D tablet out of reach of children.

Take the Telma D tablet as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.

Serious

• Angioedema or urticaria (swelling of skin and mucosa)
• Severe skin reaction (intense skin rash, itching, blistering, swelling of skin)
• Kidney disease
• Abnormal hepatic function 

Common

• Nausea
• Diarrhea
• Headache
• Dizziness
• Weakness
• Stomach pain
• Constipation
• Infection
• Inflammation of the nose
• Chest pain
• Back pain
• Indigestion
• Nervousness
• Hypertonia (increased muscle tone)
• Peripheral edema
• Sore throat
• Cough

It is suggested to monitor your blood pressure regularly to prevent hypotension. Get up slowly while rising from a lying or sitting position, as Telma D tablet may cause dizziness. It is advised to monitor electrolyte levels, as this medication may cause electrolyte fluctuations. This medicine should be used cautiously in patients with kidney impairment or severe kidney disease. Consult your doctor for advice.

1. KD Tripathi, Essentials of Medical Pharmacology, Antihypertensive Drugs, 7th Edition, 2018, 561-564.
2. Servier (Ireland) Industries Ltd., Electronic Medicines Compendium (EMC), [Revised on October 2021] [Accessed on 8th June 2023] https://www.medicines.org.uk/emc/files/pil.1152.pdf
3. Boehringer Ingelheim Ltd., Electronic Medicines Compendium (EMC), [Revised on April 2021] [Accessed on 8th June 2023], https://www.medicines.org.uk/emc/files/pil.3165.pdf
4. Boehringer Ingelheim International GmbH & Co., US Food and Drug Administration, [ Revised on May 2003] [ Accessed on 8th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/020850s011lbl.pdf